Navigation Links
Lilly and Glenmark Pharmaceuticals Announce License Agreement
Date:10/30/2007

a promising pathway for pain research. GRC 6211 has shown good potential in early-phase development and will be a strong addition to our own internal pipeline of potential pain molecules."

According to Glenn Saldanha, Managing Director and CEO of GPL, "This agreement further validates that Indian companies have the ability to do world class innovative R&D and Glenmark's leadership in the Indian drug discovery arena. We have made excellent progress in our TRPV1 program at Glenmark and are very excited to be partnering with Lilly, a world-class research-driven global pharmaceutical company."

The agreement became effective in the fourth quarter of 2007. At closing, Lilly would expect a charge to earnings for acquired in-process research and development. The amount of the charge has not yet been determined, but is estimated to be $0.02 per share. Lilly's fourth-quarter and full-year pro forma adjusted earnings per share guidance remain unchanged at $0.86 to $0.91 and $3.50 to $3.55, respectively. On a reported basis, including the charge for this transaction with Glenmark, as well as the other charges in the tables below, Lilly now expects its fourth-quarter earnings per share to be in the range of $0.81 to $0.86 and its full-year earnings per share to be in the range of $2.74 to $2.79. See the reconciliations below for further detail. Q4 Earnings per Share Reconciliation Q4 2007 Q4 2006

Expectations Results % Growth

E.P.S. (reported) $.81 to $.86 $.12 NM

Eliminate estimated in-process

research & development charge

associated with Glenmark

in-licensing .02

Eliminate estimated in-process

research & development charge

associated with MacroGenics

in-licensing .03 -

Eliminate product liability charge - .42

El
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer Treatment
2. Making Science Personal: Lilly Oncology to Unveil 76 Studies at ASCO 2007
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
11. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 24, 2014  Novastem, a leader ... first patient in its study for ischemic stroke ... Stroke Association, ischemic strokes account for 87 percent ... qualified patients in the study, entitled "Internal Research ... Allogeneic Mesenchymal Stem Cells and Intrathecal Administration of ...
(Date:12/24/2014)... PRINCETON, N.J. , Dec. 24, 2014 /PRNewswire/ ... Company), a late-stage biopharmaceutical company developing products that ... inflammation, oncology and biodefense, announced today that on ... registered public offering. The Company raised ... offering and intends to use the net proceeds ...
(Date:12/24/2014)... YORK and LONDON , ... global orthopedic industry are expected to grow at an ... in terms of value and volume. Hip, knee and ... developed world while in emerging economies they have a ... rates are challenging the use of composites. Non-metallic orthopedic ...
Breaking Medicine Technology:Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 3
... April 4, 2012  Syndicus, Inc. and Fayetteville, ... forged a strategic alliance that will ultimately ... paper-based records to federally mandated electronic health ... companies will work closely to promote and ...
... 4, 2012   CoreBrand , a leading brand strategy ... Branding Index® , which provides continuous benchmarking data, insights ... 54 industries, has recently been engaged by leading U.S. ... consumer industries for its expertise in crisis brand management. ...
Cached Medicine Technology:Syndicus, Inc. Scientific Services, SOAPware Announce Strategic Alliance 2Fortune 100 Companies Turning to CoreBrand for Its Expertise in Crisis Brand Management 2Fortune 100 Companies Turning to CoreBrand for Its Expertise in Crisis Brand Management 3
(Date:12/26/2014)... 2014 Cooking and warming equipment ... of 5. This score reflects slightly positive negotiation conditions ... specialization, low switching costs and a low level of ... low availability of substitutes for cooking and warming equipment ... and aluminum, key inputs in the production process of ...
(Date:12/26/2014)... 26, 2014 India Network Foundation, a ... the USA, announced today a new version of “ ... choosing the right plan for their visiting parents. The ... of the selection process when choosing an insurance plan ... with only a few clicks. Many elderly Asian Indian ...
(Date:12/25/2014)... This is a professional and in-depth study on ... a focus on the Chinese market. The report provides ... manufacturers and is a valuable source of guidance and ... This report provides a basic overview of the industry ... part, the report presents the company profile, product specifications, ...
(Date:12/25/2014)... months the trends for evening dresses shift and ... of the hottest styles in the next few months.” The ... 26 A-line sweetheart evening dresses, and announces the availability of ... trying our best to help a lady to show off ... prices, we provide discounted delivery costs to our customers worldwide. ...
(Date:12/25/2014)... BambooFlooringChina.com sells many bamboo products and the ... the company announces big discounts on its bamboo ... , BambooFlooringChina.com is the world’s leader in bamboo flooring. ... until Jan. 20, 2015. , The bamboo mats are ... natural thread. All the bamboo strips for the mats ...
Breaking Medicine News(10 mins):Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 2Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 3Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2
... (June 17, 2010)The Alliance for Academic Internal Medicine (AAIM) has ... education (GME) funding. In light of the current ... Commission,s (MedPAC,s) June 2010 report, AAIM encourages GME reform to ... The AAIM Principles for GME Reform ...
... ... medication expenses , ... Westerville, Ohio (PRWEB) June 17, 2010 -- Progressive Medical, Inc. ( http://www.progressive-medical.com ) announced ... medication spending on workers’ compensation claims from 2008 to 2009 for Progressive Medical clients, ...
... Normal weight and underweight teenage girls who falsely believe ... succumbing to unnecessary and unsafe weight-loss behaviors than girls ... new research by a University of Illinois expert in ... a professor of social work and of medicine at ...
... ... cost-effective cell culture media supplement that is consistent and animal component free. , ... Fort Collins, CO (PRWEB) ... steer cell culture scientists to re-evaluate their use of native transferrin and iron chelators ...
... validated by others brings mental satisfaction, study finds , THURSDAY, ... often leads to a sense of satisfaction, and a new ... area of the brain is activated when people agree with ... used functional MRI scans to monitor activity in the ventral ...
... ... and a lot of potential solutions to water scarcity have steep energy costs. , ... (PRWEB) June 17, 2010 -- This ... energy is critical to treating and moving water. According to a new special report in ...
Cached Medicine News:Health News:Progressive Medical Releases 2010 Workers' Compensation Drug Spend Analysis 2Health News:Body-image distortion predicts onset of unsafe weight-loss behaviors 2Health News:Body-image distortion predicts onset of unsafe weight-loss behaviors 3Health News:Body-image distortion predicts onset of unsafe weight-loss behaviors 4Health News:Body-image distortion predicts onset of unsafe weight-loss behaviors 5Health News:Study Demonstrates a Safe and Cost Effective Source of Recombinant Human Transferrin 2Health News:Study Demonstrates a Safe and Cost Effective Source of Recombinant Human Transferrin 3Health News:Shared Opinions Light Up Brain's 'Reward Center' 2Health News:Green Energy May Drain Our Water Supplies 2Health News:Green Energy May Drain Our Water Supplies 3
... Blue Line® uncuffed endotracheal tubes ... Murphy styles, in standard or ... adult and pediatric uncuffed endotracheal ... polyvinyl chloride with a radiopaque ...
Portex® Blue Line® cuffed endotracheal tubes come in a wide selection of sizes, each with a standard 15 mm ISO connector., ,Portex® Blue Line® endotracheal tubes are recognized world...
... PVC. 2 eyes, oral. Marked with ... X-ray opaque line. Graduated. Single use. ... reduce kinking of the tube by ... adapts to the anatomical situation at ...
... Tube with stylet inside. Sterile, Latex ... Rusch endotracheal tube with a preloaded ... saving you time and storage space. ... easy identification and has a stopper ...
Medicine Products: